DYN
Dyne Therapeutics, Inc
$29.99
Earnings Summary
Net Profits | $-97.13Mn |
Highlights
Net Profits:
Dyne Therapeutics, Inc’s net profit fell -61.31% since last year same period to $-97.13Mn in the Q3 2024. On a quarterly growth basis, Dyne Therapeutics, Inc has generated -49.19% fall in its net profits since last 3-months.
Earnings per share (EPS) Estimates
Earnings per share (EPS) estimates of the Dyne Therapeutics, Inc post its latest quarter earnings
EPS Estimate Current Quarter | -0.71 |
EPS Estimate Current Year | -0.71 |
Highlights
EPS Estimate Current Quarter:
Dyne Therapeutics, Inc’s earning per share (EPS) estimates for the current quarter stand at -0.71 - a 1.39% jump from last quarter’s estimates.
EPS Estimate Current Year:
Dyne Therapeutics, Inc’s earning per share (EPS) estimates for the current year stand at -0.71.
Key Ratios
Key ratios of the Dyne Therapeutics, Inc post its Q3 2024 earnings
Earning Per Share (EPS) | -0.96 |
Highlights
Earning Per Share (EPS):
Dyne Therapeutics, Inc’s earning per share (EPS) jumped 2.75% since last year same period to -0.96 in the Q3 2024. This indicates that the Dyne Therapeutics, Inc has generated 2.75% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2024-08-12 | -0.72 | -0.7 | 2.78% |
2024-09-30 | -0.71 | -0.96 | -35.61% |
2024-05-02 | -0.8 | -0.81 | -1.25% |
₹0 US Stocks a/c Opening Fee